NYSEMKT: KAPA
Kairos Pharma Ltd Stock Ownership - Who owns Kairos Pharma?

Insider buying vs selling

Have Kairos Pharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KAPA insiders and whales buy or sell their stock.

KAPA Shareholders

What type of owners hold Kairos Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John S. Yu118.39%5,546,677$2.42MInsider
Neil Bhowmick28.00%1,311,739$571.92kInsider
Ramachandran Murali6.39%299,529$130.59kInsider
Doug Samuelson6.25%293,039$127.77kInsider
Hyun W. Bae1.57%73,370$31.99kInsider
Rahul Singhvi1.05%49,204$21.45kInsider
Hansoo Michael Keyoung0.62%29,084$12.68kInsider
Jane Street Group LLC0.00%13$5.67Institution
Vanguard Capital Management LLC0.00%9$3.92Institution
Vanguard Fiduciary Trust Co0.00%6$2.62Institution

1 of 2

KAPA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KAPA0.00%100.00%
NRSN0.00%100.00%Net Buying
SXTP0.01%79.54%Net Buying
DCOY0.00%100.00%Net Selling
GNPX0.00%100.00%Net Selling

Kairos Pharma Stock Ownership FAQ

Who owns Kairos Pharma?

Kairos Pharma (NYSEMKT: KAPA) is owned by 0.00% institutional shareholders, 162.28% Kairos Pharma insiders, and 0.00% retail investors. John S. Yu is the largest individual Kairos Pharma shareholder, owning 5.55M shares representing 118.39% of the company. John S. Yu's Kairos Pharma shares are currently valued at $2.42M.

If you're new to stock investing, here's how to buy Kairos Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.